AEM Expands Elements Platform to Deliver Full-Spectrum Environmental Resilience October 5, 2026 Elements 360, Elements Weather, and Elements Protect give organizations purpose-built applications for every environmental risk decision, helping them plan earlier, respond faster, and protect people, infrastructure, and operations when conditions threaten.
e.l.f. Expands Into Fragrance and Body Care Categories with Launch of e.l.f. POP, Debuting Limited-Edition Holiday “Spicy Bundt Nice” Collection Inspired by Tromsø, Norway October 5, 2026 e.l.f. POP transports e.l.f.'s community to sensorial destinations, starting with an arctic-inspired holiday launch
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases October 2, 2026 Intranasal pertussis vaccine candidate BPZE1 demonstrates robust nasal mucosal and systemic immune responses with a favorable safety profile in children ages 6 through 17 years First pediatric clinical trial builds on 5 prior adult BPZE1 clinical studies Demonstrates safety and immunogenicity of BPZE1 in acellular pertussis vaccine primed individuals No interference observed when BPZE1 co-administered with diphtheria and tetanus antigens
Wärtsilä and RCT Solutions Launch Valo, a New Energy Storage Integrator with 20 GWh on Day One October 1, 2026 Proven project execution, intelligent software, and engineering expertise combine to deliver safe, reliable energy storage at scale
Elliptic Sets the Engineering Bar for On-Chain Risk With “Built for Compliance” Paper as New Rules Take Hold and Banks Launch a Joint Stablecoin October 1, 2026 Built for compliance arrives as crypto compliance rules tighten worldwide and a bank-led stablecoin enters the market
Moody’s Analytics and Allvue Launch Credit Risk Model to Identify Early Signs of Borrower Stress in Private Credit October 1, 2026 Moody’s Analytics EDF-X Private Credit Model, powered by Allvue data, gives investors and lenders an earlier view of borrower stress in a rapidly growing market
NICE issues final draft guidance recommending ▼ Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales October 1, 2026 FOR UK HEALTHCARE/TRADE MEDIA ONLY Sobi® UK today announced that the National Institute for Health and Care Excellence (NICE) has issued final draft guidance which recommends Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales, only if response to diet and conventional triglyceride-lowering treatments (such [...]
Powerful Medical and corpuls Partner to Bring Queen of Hearts AI-Powered Heart Attack Detection to Prehospital Care October 1, 2026 Queen of Hearts, the AI ECG model that detects heart attacks standard criteria miss, will be integrated into corpuls devices and telemedicine systems used by emergency care professionals in over 70 countries globally
ROYC Group Launches ROYC Operating System as a Standalone Enterprise Software Platform October 1, 2026 ROYC Group today announced the launch of ROYC Operating System (ROYC OS) as a standalone software platform for fund managers, banks and wealth managers across private markets. The software is now available separately from ROYC’s existing structuring, fund operations and distribution services. Proven in production, at scale ROYC used its structuring and fund operations experience [...]
Dunbar Pharma Supplies API for UK’s First Plant-Derived Dronabinol Oral Spray October 1, 2026 Irish manufacturer’s API used in additional oral formulation through IPS Pharma; Company to expand Athlone production in 2027